| Papillary renal cell carcinoma with cutaneous metastases. | |
| | |
MedLine Citation:
|
PMID: 20234300 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Cutaneous metastasis is a rare form of presentation of renal cell carcinoma (RCC). Case reports and case series of RCC with skin metastasis in the English literature from 1972 to 2008 were identified by searching the keywords "renal cell cancer," "papillary renal cell tumor," "skin metastasis," and "cutaneous metastasis" in the National Library of Medicine, PUBMED, OVID, and EMBASE search engines. Although a few cases of RCC with skin metastasis are reported in the literature, almost all are clear cell histologic type. We are reporting a unique case of papillary RCC with cutaneous metastases diagnosed at our institution along with a comprehensive literature review of papillary RCC etiology, clinical presentation, prognosis, diagnosis, and the treatment options that are currently available. |
| | |
Authors:
|
Nandakumar Srinivasan; Aneesh Pakala; Aref Al-Kali; Shradha Rathi; Waqar Ahmad |
Publication Detail:
|
Type: Case Reports; Journal Article |
Journal Detail:
|
Title: The American journal of the medical sciences Volume: 339 ISSN: 1538-2990 ISO Abbreviation: Am. J. Med. Sci. Publication Date: 2010 May |
Date Detail:
|
Created Date: 2010-05-13 Completed Date: 2010-06-02 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 0370506 Medline TA: Am J Med Sci Country: United States |
Other Details:
|
Languages: eng Pagination: 458-61 Citation Subset: AIM; IM |
Affiliation:
|
Department of Internal Medicine, Health Science Center, University of Oklahoma, Oklahoma City, Oklahoma 73190, USA. nandakumar-srinivasan@ouhsc.edu |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Antineoplastic Agents
/
therapeutic use Carcinoma, Renal Cell / drug therapy, pathology* Humans Male Middle Aged Sirolimus / analogs & derivatives, therapeutic use Skin Neoplasms / drug therapy, secondary* |
| Chemical | |
Reg. No./Substance:
|
0/Antineoplastic Agents; 0/temsirolimus; 53123-88-9/Sirolimus |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Exploring the effect of parathyroidectomy for tertiary hyperparathyroidism after kidney transplantat...
Next Document: Combination Therapy of Calcium Channel Blocker and Angiotensin II Receptor Blocker Reduces Augmentat...